Belite Bio, Inc. (BLTE)
164.11
-0.09
(-0.05%)
USD |
NASDAQ |
Jan 08, 16:00
164.11
0.00 (0.00%)
After-Hours: 19:52
Belite Bio Research and Development Expense (Annual): 29.94M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ocugen, Inc. | 30.16M |
| Ionis Pharmaceuticals, Inc. | 901.53M |
| Ligand Pharmaceuticals, Inc. | 21.42M |
| IDEAYA Biosciences, Inc. | 294.67M |
| Terns Pharmaceuticals, Inc. | 70.11M |